CLINICAL TRIALS PROFILE FOR RELAFEN
✉ Email this page to a colleague
All Clinical Trials for RELAFEN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00688961 ↗ | Effects of Omacor and Aspirin on Platelet Function | Completed | Sanford Research | Early Phase 1 | 2007-06-01 | Omacor (now Lovaza) is a pharmaceutical omega-3 fatty acid product. Omega-3 fatty acids can affect blood clotting by altering the function of the blood platelets. Aspirin can do the same. The purpose of this study is to determine the individual and combined effects of these two agents on platelet function using a whole blood method. |
| NCT01164813 ↗ | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions | Completed | Dr. Reddy's Laboratories Limited | Phase 1 | 2006-03-01 | The purpose of this study is: - To Assess the bioequivalence study of Nabumetone 750 mg tablets and Relafen® 750 mg tablets in healthy, adult, human subjects under fasting conditions with a washout period of 14 days. - To monitor adverse events and ensure the safety of subjects. |
| NCT01164826 ↗ | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Conditions | Completed | Dr. Reddy's Laboratories Limited | Phase 1 | 2006-03-01 | The purpose of this study is: - To Assess the bioequivalence study of Nabumetone 750 mg tablets and Relafen® 750 mg tablets in healthy, adult, human subjects under fed conditions with a washout period of 16 days. - To monitor adverse events and ensure the safety of subjects. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RELAFEN
Condition Name
Clinical Trial Locations for RELAFEN
Trials by Country
Clinical Trial Progress for RELAFEN
Clinical Trial Phase
Clinical Trial Sponsors for RELAFEN
Sponsor Name
